<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01603706</url>
  </required_header>
  <id_info>
    <org_study_id>SHEBA-12-9349-MG-CTIL</org_study_id>
    <nct_id>NCT01603706</nct_id>
  </id_info>
  <brief_title>Radial Strain ECHO-Guided Implantation of Cardiac Resynchronization Therapy</brief_title>
  <acronym>RAISE-CRT</acronym>
  <official_title>Radial Strain Imaging-Guided Lead Placement for Improving Response to Cardiac Resynchronization Therapy in Patients With Ischemic Cardiomyopathy: A Randomized Clinical Trial</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Sheba Medical Center</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Tel-Aviv Sourasky Medical Center</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Rabin Medical Center</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Rambam Health Care Campus</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Kaplan Medical Center</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Soroka University Medical Center</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Mayo Clinic</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Sheba Medical Center</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to evaluate the use of radial strain imaging using speckle
      tracking analysis to predict the response to CRT in patients with ischemic cardiomyopathy
      (ICMP) with NYHA functional class 2-4 heart failure and a standard guideline-based CRT
      indication. Thus assessing the value of lead localization determined by radial strain imaging
      in a prospective, randomized manner.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      In this study we propose to evaluate the utility of radial strain imaging using speckle
      tracking to predict the response to CRT in patients with ischemic cardiomyopathy (ICMP) with
      NYHA functional class 2-4 heart failure and a standard guideline-based CRT indication, and to
      determine the value of lead localization determined by radial strain imaging in a
      prospective, randomized manner. We will compare two randomized groups of CRT recipients
      implanted with CRT-D systems. In the control group, implantation will be performed in the
      usual manner and the lead will be placed at the discretion of the implanting physician,
      preferably at posterolateral LV sites . In the study group, leads will be placed in areas of
      latest contraction that lack significant scar, as determined by speckle tracking imaging. The
      primary outcome measure for comparison between the 2 groups will be echocardiographic
      response (as assessed by percent reduction in left ventricular end systolic volumes) at 6
      months post-implantation. In addition, clinical response parameters will also be measured as
      secondary end points.

      We hypothesize that 1) patients showing greater dyssynchrony and/or discoordination index
      with speckle tracking will derive a significantly greater response to cardiac
      resynchronization therapy; and 2) patients allocated to the image-guided LV lead placement
      group will derive a significantly greater response to CRT than patients in the non- guided
      implantation (control) group.

      If radial strain imaging proves useful for improving the CRT response rate and identification
      of patients likely to respond, it will have important clinical and economic implications by
      improving individual outcomes and more effective utilization of constrained health care
      resources. Furthermore, if echo-guided lead implantation proves to be effective in reducing
      the relatively large non-response rate to cardiac resynchronization therapy, it will likely
      result in increased device utilization among eligible heart failure patients.

      Specific Aims Aim #1: To show that in patients with ischemic cardiomyopathy, implantation of
      a CRT LV lead guided by radial strain imaging results in a significantly greater
      echocardiographic and clinical response to cardiac resynchronization therapy compared with
      conventional implantation techniques.

      Aim #2: To show that speckle tracking strain data can be used to identify the degree of
      echocardiographic response to CRT, using both dyssynchrony (time to peak strain ) and
      discoordination indices.

      Aim #3:

      The Paieon substudy will comprise 40 patients enrolled at 3 centers, for whom additional
      information mechanical dyssynchrony, using the Paieon CardioGuide motion map, will be
      collected during device implantation as detailed below The primary aim of the study is to
      relate data of mechanical dyssynchrony obtained from angiography through the Paieon
      CardioGuide motion map to dyssynchrony data obtained from the echocardiogram.

      The dyssynchrony data will not be available to the treating physicians and will not be used
      to direct the LV lead location.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>May 2012</start_date>
  <completion_date type="Actual">October 2017</completion_date>
  <primary_completion_date type="Actual">October 2017</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single (Participant)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Demonstrating Percent reduction in left ventricular end systolic (LVESV) at 6 months compared with baseline values.</measure>
    <time_frame>within 12 month from enrollment.</time_frame>
    <description>To show that in patients with ischemic cardiomyopathy, implantation of a CRT LV lead guided by radial strain imaging results in a significantly greater echocardiographic and clinical response to cardiac resynchronization therapy compared with conventional implantation techniques.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Clinical Improvement</measure>
    <time_frame>Within 12 month from enrollment</time_frame>
    <description>A combined clinical event rate - change in NYHA, hospitalization for heart failure, death</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Echocardiographic improvement</measure>
    <time_frame>Within 12 month from enrollment</time_frame>
    <description>&gt;15% improvement in LVESV, &gt;10% improvement in LVEDV, 5% absolute improvement of LVEF</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Improvement in wellbeing</measure>
    <time_frame>Within 12 month from enrollment</time_frame>
    <description>10 point improvement in Minnesota Living with Heart Failure Questionnaire (MLWHF), 10% improvement of 6 minute walk test(6MWT)</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">172</enrollment>
  <condition>Ischemic Cardiomyopathy</condition>
  <arm_group>
    <arm_group_label>Echo guided implantation group</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Echo guided implantation group Patients undergoing speckle tracking based LV lead implantation.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Conventional implantation group</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>Patients undergoing conventional LV lead implantation</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Echo guided implantation group</intervention_name>
    <description>Lead placement according echo strain imaging result</description>
    <arm_group_label>Echo guided implantation group</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patients with ischemic CMP based on evidence of prior MI by history, coronary
             angiography/revascularization or imaging

          -  AHA ACC or ESC EHRA Guideline-based indication (Class I or II) for CRT and NYHA class
             II-IV heart failure

          -  ECG wide QRS and :

        QRS &gt; 120 msec in NYHA III- IV

        OR

        CLBBB or QRS &gt; 150 in NYHA =II

          -  Sinus rhythm predominant rhythm (PAF not an exclusion)

          -  All must be candidates for De novo CRT-D implantation with LV lead via transvenous
             approach or patients previously implanted with pacemaker or ICD with &lt;20% pacing over
             the last three months who are undergoing CRT-D upgrade.

          -  Patient provides informed consent, tolerate a pectoral implant, agree to comply with
             the protocol, and maintain scheduled follow-up visits.

        Exclusion Criteria:

          -  Permanent or persistent atrial fibrillation

          -  Advanced renal disease (Cr &gt;=2.5 mg/dL)

          -  Advanced comorbidities with life expectancy of &lt;1 year

          -  Patients on waiting list for heart transplantation

          -  Requiring intravenous amines (continuous or or intermittent amine drip therapy)

          -  Severe chronic pulmonary disease (simulating heart failure)

          -  Severe (untreated) organic mitral valve disease

          -  Poorly treated hypertension

          -  History of myocardial infarction &lt; 3 months; unstable angina &lt; 1m, CABG &lt;3 months; PCI
             &lt;3 months

          -  Mechanical TC valve

          -  Previously implanted CRT system

          -  Poorly visualized cardiac chamber dimensions in an echocardiogram performed prior to
             enrollment - please help us define

          -  Pregnancy or child-bearing potential in the absence of accepted forms of birth control

          -  Concurrent enrollment in other study
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Ilan Goldenberg, Prof.</last_name>
    <role>Study Director</role>
    <affiliation>The Israeli Society for the Prevention of Heart Attacks</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Michael Glikson, Prof.</last_name>
    <role>Principal Investigator</role>
    <affiliation>Sheba Medical Center</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Paul Friedman, Prof.</last_name>
    <role>Principal Investigator</role>
    <affiliation>Mayo Clinic</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Mayo Clinic</name>
      <address>
        <city>Rochester</city>
        <state>Minnesota</state>
        <zip>55905</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Barzilai Medical Center</name>
      <address>
        <city>Ashkelon</city>
        <country>Israel</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Carmel Medical Center</name>
      <address>
        <city>Haifa</city>
        <country>Israel</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Rambam Medical Center</name>
      <address>
        <city>Haifa</city>
        <country>Israel</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Shaare Zedek</name>
      <address>
        <city>Jerusalem</city>
        <country>Israel</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Rabin Medical Center</name>
      <address>
        <city>Petah Tikva</city>
        <country>Israel</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Sheba Medical Center</name>
      <address>
        <city>Ramat Gan</city>
        <country>Israel</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Kaplan Medical Center</name>
      <address>
        <city>Rehovot</city>
        <country>Israel</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Sorasky Medical Center</name>
      <address>
        <city>Tel Aviv</city>
        <country>Israel</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Israel</country>
    <country>United States</country>
  </location_countries>
  <reference>
    <citation>Yu CM, Sanderson JE, Gorcsan J 3rd. Echocardiography, dyssynchrony, and the response to cardiac resynchronization therapy. Eur Heart J. 2010 Oct;31(19):2326-37. doi: 10.1093/eurheartj/ehq263. Epub 2010 Aug 13. Review.</citation>
    <PMID>20709721</PMID>
  </reference>
  <reference>
    <citation>Miyazaki C, Redfield MM, Powell BD, Lin GM, Herges RM, Hodge DO, Olson LJ, Hayes DL, Espinosa RE, Rea RF, Bruce CJ, Nelson SM, Miller FA, Oh JK. Dyssynchrony indices to predict response to cardiac resynchronization therapy: a comprehensive prospective single-center study. Circ Heart Fail. 2010 Sep;3(5):565-73. doi: 10.1161/CIRCHEARTFAILURE.108.848085. Epub 2010 Jul 20.</citation>
    <PMID>20647479</PMID>
  </reference>
  <reference>
    <citation>Chung ES, Leon AR, Tavazzi L, Sun JP, Nihoyannopoulos P, Merlino J, Abraham WT, Ghio S, Leclercq C, Bax JJ, Yu CM, Gorcsan J 3rd, St John Sutton M, De Sutter J, Murillo J. Results of the Predictors of Response to CRT (PROSPECT) trial. Circulation. 2008 May 20;117(20):2608-16. doi: 10.1161/CIRCULATIONAHA.107.743120. Epub 2008 May 5.</citation>
    <PMID>18458170</PMID>
  </reference>
  <reference>
    <citation>Delgado V, van Bommel RJ, Bertini M, Borleffs CJ, Marsan NA, Arnold CT, Nucifora G, van de Veire NR, Ypenburg C, Boersma E, Holman ER, Schalij MJ, Bax JJ. Relative merits of left ventricular dyssynchrony, left ventricular lead position, and myocardial scar to predict long-term survival of ischemic heart failure patients undergoing cardiac resynchronization therapy. Circulation. 2011 Jan 4;123(1):70-8. doi: 10.1161/CIRCULATIONAHA.110.945345. Epub 2010 Dec 20.</citation>
    <PMID>21173353</PMID>
  </reference>
  <reference>
    <citation>Becker M, Hoffmann R, Kühl HP, Grawe H, Katoh M, Kramann R, Bücker A, Hanrath P, Heussen N. Analysis of myocardial deformation based on ultrasonic pixel tracking to determine transmurality in chronic myocardial infarction. Eur Heart J. 2006 Nov;27(21):2560-6. Epub 2006 Oct 11.</citation>
    <PMID>17035253</PMID>
  </reference>
  <reference>
    <citation>Delgado V, Ypenburg C, van Bommel RJ, Tops LF, Mollema SA, Marsan NA, Bleeker GB, Schalij MJ, Bax JJ. Assessment of left ventricular dyssynchrony by speckle tracking strain imaging comparison between longitudinal, circumferential, and radial strain in cardiac resynchronization therapy. J Am Coll Cardiol. 2008 May 20;51(20):1944-52. doi: 10.1016/j.jacc.2008.02.040.</citation>
    <PMID>18482662</PMID>
  </reference>
  <reference>
    <citation>Tanaka H, Nesser HJ, Buck T, Oyenuga O, Jánosi RA, Winter S, Saba S, Gorcsan J 3rd. Dyssynchrony by speckle-tracking echocardiography and response to cardiac resynchronization therapy: results of the Speckle Tracking and Resynchronization (STAR) study. Eur Heart J. 2010 Jul;31(14):1690-700. doi: 10.1093/eurheartj/ehq213. Epub 2010 Jun 8.</citation>
    <PMID>20530502</PMID>
  </reference>
  <reference>
    <citation>Kirn B, Jansen A, Bracke F, van Gelder B, Arts T, Prinzen FW. Mechanical discoordination rather than dyssynchrony predicts reverse remodeling upon cardiac resynchronization. Am J Physiol Heart Circ Physiol. 2008 Aug;295(2):H640-6. doi: 10.1152/ajpheart.00106.2008. Epub 2008 May 30.</citation>
    <PMID>18515652</PMID>
  </reference>
  <reference>
    <citation>Wang CL, Wu CT, Yeh YH, Wu LS, Chang CJ, Ho WJ, Hsu LA, Luqman N, Kuo CT. Recoordination rather than resynchronization predicts reverse remodeling after cardiac resynchronization therapy. J Am Soc Echocardiogr. 2010 Jun;23(6):611-20. doi: 10.1016/j.echo.2010.03.012. Epub 2010 Apr 24.</citation>
    <PMID>20418055</PMID>
  </reference>
  <reference>
    <citation>Wang CL, Powell BD, Redfield MM, Miyazaki C, Fine NM, Olson LJ, Cha YM, Espinosa RE, Hayes DL, Hodge DO, Lin G, Friedman PA, Oh JK. Left ventricular discoordination index measured by speckle tracking strain rate imaging predicts reverse remodelling and survival after cardiac resynchronization therapy. Eur J Heart Fail. 2012 May;14(5):517-25. doi: 10.1093/eurjhf/hfs025. Epub 2012 Mar 12.</citation>
    <PMID>22411692</PMID>
  </reference>
  <reference>
    <citation>Sung RK, Foster E. Assessment of systolic dyssynchrony for cardiac resynchronization therapy is not clinically useful. Circulation. 2011 Feb 15;123(6):656-62. doi: 10.1161/CIRCULATIONAHA.110.954420.</citation>
    <PMID>21321181</PMID>
  </reference>
  <reference>
    <citation>Kindermann M, Fröhlig G, Doerr T, Schieffer H. Optimizing the AV delay in DDD pacemaker patients with high degree AV block: mitral valve Doppler versus impedance cardiography. Pacing Clin Electrophysiol. 1997 Oct;20(10 Pt 1):2453-62.</citation>
    <PMID>9358487</PMID>
  </reference>
  <verification_date>October 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>May 14, 2012</study_first_submitted>
  <study_first_submitted_qc>May 20, 2012</study_first_submitted_qc>
  <study_first_posted type="Estimate">May 22, 2012</study_first_posted>
  <last_update_submitted>October 18, 2017</last_update_submitted>
  <last_update_submitted_qc>October 18, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">October 19, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Sheba Medical Center</investigator_affiliation>
    <investigator_full_name>Prof. Michael Glikson</investigator_full_name>
    <investigator_title>Prof. Michael Glikson, MD.</investigator_title>
  </responsible_party>
  <keyword>Heart failure</keyword>
  <keyword>Cardiac Resynchronization Therapy</keyword>
  <keyword>CRT</keyword>
  <keyword>Radial strain echocardiography</keyword>
  <keyword>Ischemic cardiomyopathy</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Ischemia</mesh_term>
    <mesh_term>Cardiomyopathies</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

